# Comparison of IPACK Block and PCI for Postoperative Analgesia and Function Recovery Following Total Knee Arthroplasty

> **NCT05943080** · NA · COMPLETED · sponsor: **Kirsehir Ahi Evran Universitesi** · enrollment: 195 (actual)

## Conditions studied

- Total Knee ArthroplastyKnee Pain, Functionality

## Interventions

- **DRUG:** PCI (0.25% marcaine+ 2.0 μg/mL of adrenaline + %0.9 saline)
- **DRUG:** IPACK(0.25% marcaine+ 2.0 μg/mL of adrenaline + %0.9 saline)
- **DRUG:** ACB ( 0.25% marcaine + %0.9 saline)

## Key facts

- **NCT ID:** NCT05943080
- **Lead sponsor:** Kirsehir Ahi Evran Universitesi
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-01
- **Primary completion:** 2023-08-10
- **Final completion:** 2023-12-15
- **Target enrollment:** 195 (ACTUAL)
- **Last updated:** 2024-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05943080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05943080, "Comparison of IPACK Block and PCI for Postoperative Analgesia and Function Recovery Following Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05943080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*